文献速递自身免疫性与大疱性皮肤病皮肤肿瘤

全外显子组测序揭示PNP相关单中心Castleman病的基因组特征及IL6ST变异预后标志物

Whole-Exome Sequencing Reveals the Genomic Profile and IL6ST Variants as a Prognostic Biomarker of Paraneoplastic Pemphigus-Associated Unicentric Castleman Disease.
PubMed 文献 · J Invest Dermatol · 2023-10-14

本研究对28对肿瘤-正常配对样本和9例仅肿瘤样本进行全外显子组测序,描绘中国PNP相关单中心Castleman病患者的基因组图谱。IL6ST变异与较差的总生存期相关(P = .02),并据此将疾病分为4个基因组亚组。

要点

  • PNP相关UCD中IL6ST和PDGFRB为最常见突变基因,频率均为32%。
  • IL6ST变异与较差的总生存期相关(P = .02)。
  • 基于突变特征可将PNP相关UCD分为IL6ST、PDGFRB、IL6ST-PDGFRB和未知4个基因组亚组。

核心结论

  • 研究定义了PNP相关UCD的分子图谱,并鉴定出IL6ST变异作为潜在预后预测分子标志物。

研究设计与样本

  • 对28对肿瘤-正常配对样本和9例仅肿瘤样本进行全外显子组测序,分析中国PNP相关UCD患者的基因组 landscape。

主要发现

  • IL6ST和PDGFRB是最常见突变基因(32%),其次为DPP6(18%)和MUC4(18%)。
  • 信号分子与相互作用、细胞过程及信号转导通路富集。
  • 较差的总生存期与IL6ST变异相关(P = .02)。
  • 将PNP相关UCD分为4个基因组亚组:IL6ST、PDGFRB、IL6ST-PDGFRB和未知亚组。

临床怎么用

  • IL6ST变异可能作为预测PNP相关UCD预后的分子生物标志物。
  • 研究结果可能为该严重疾病提供治疗靶点。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Unicentric Castleman disease (UCD) is a rare lymphoproliferative disorder. Paraneoplastic pemphigus (PNP) is a major complication associated with poor UCD prognosis. However, the genomic profiles and prognostic biomarkers of PNP-associated UCD remain unclear. In this study, we performed whole-exome sequencing analysis for 28 matched tumor-normal pairs and 9 tumor-only samples to define the genomic landscape of Chinese patients with PNP-associated UCD. An integrative analysis was performed to identify somatic variants, the mutational signatures, and key pathways in tumors. Besides, we analyzed the relationship among mutated genes, clinical characteristics, and prognosis. Sixty-one somatic mutant genes were identified in >1 patient with PNP-associated UCD. Specifically, IL6ST and PDGFRB were the most frequently mutated genes (32%), followed by DPP6 (18%) and MUC4 (18%). Signaling molecules and interactions, cellular processes, and signal transduction pathways were enriched. Furthermore, we found that poor overall survival was related to IL6ST variants (P = .02). Finally, we classified PNP-associated UCD into 4 genomic subgroups: IL6ST, PDGFRB, IL6ST-PDGFRB, and an unknown subgroup. In summary, we defined the molecular profile of PNP-associated UCD and identified a potential molecular biomarker for predicting prognosis, which may provide therapeutic targets for treating this severe disorder.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Wang S, Wang R, Shang P, et al. Whole-Exome Sequencing Reveals the Genomic Profile and IL6ST Variants as a Prognostic Biomarker of Paraneoplastic Pemphigus-Associated Unicentric Castleman Disease. J Invest Dermatol. 2023. PMID: 37839777. doi:10.1016/j.jid.2023.07.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。